Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Apex Healthcare Bhd's annualized net income for the quarter that ended in Sep. 2025 was RM62.4 Mil. Apex Healthcare Bhd's average shareholder tangible equity for the quarter that ended in Sep. 2025 was RM782.1 Mil. Therefore, Apex Healthcare Bhd's annualized Return-on-Tangible-Equity for the quarter that ended in Sep. 2025 was 7.98%.
The historical rank and industry rank for Apex Healthcare Bhd's Return-on-Tangible-Equity or its related term are showing as below:
XKLS:7090'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 8.32 Med: 12.83 Max: 54.25
Current: 8.32
During the past 13 years, Apex Healthcare Bhd's highest Return-on-Tangible-Equity was 54.25%. The lowest was 8.32%. And the median was 12.83%.
XKLS:7090's Return-on-Tangible-Equity is not ranked
in the Medical Distribution industry.
Industry Median: 8.81
vs XKLS:7090: 8.32
Apex Healthcare Bhd (XKLS:7090) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Apex Healthcare Bhd Return-on-Tangible-Equity Related Terms
Apex Healthcare Bhd Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Apex Healthcare Bhd's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apex Healthcare Bhd Return-on-Tangible-Equity Chart
XKLS:7090 vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Apex Healthcare Bhd's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apex Healthcare Bhd Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Apex Healthcare Bhd's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Apex Healthcare Bhd's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Sep. 2025) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 7.98% mean?
Apex Healthcare Bhd (XKLS:7090) has a Return-on-Tangible-Equity of 7.98% as of Sep. 2025. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Apex Healthcare Bhd and its competitors. This is 38% below median its historical median of 12.83. Over the past decade, Apex Healthcare Bhd's Return-on-Tangible-Equity has ranged from 8.32 to 54.25.
Is Apex Healthcare Bhd's Return-on-Tangible-Equity too high?
Apex Healthcare Bhd's current Return-on-Tangible-Equity of 7.98% is 38% below median its 10-year median of 12.83. Over the past 10 years, this metric has ranged from a low of 8.32 to a high of 54.25. The Medical Distribution industry median Return-on-Tangible-Equity is 8.81. Apex Healthcare Bhd's value of 7.98% is 9.4% below this industry median. Overall, Apex Healthcare Bhd has a GF Score™ of 63/100, reflecting its overall financial health beyond just this single metric.
How does Apex Healthcare Bhd's Return-on-Tangible-Equity compare to MCK and COR?
Apex Healthcare Bhd's Return-on-Tangible-Equity of 7.98% can be compared against companies in the Medical Distribution industry. The industry median Return-on-Tangible-Equity is 8.81. Apex Healthcare Bhd's value of 7.98% is 9.4% below this benchmark. Historically, Apex Healthcare Bhd's own Return-on-Tangible-Equity has ranged from 8.32 to 54.25 over the past decade. While the company's 10-year median is 12.83 vs. the industry median of 8.81, Apex Healthcare Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 8.81, based on 111 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apex Healthcare Bhd's current Return-on-Tangible-Equity of 7.98% is 9.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Apex Healthcare Bhd and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 8.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apex Healthcare Bhd's current Return-on-Tangible-Equity is 7.98%, which is 38% below median its own 10-year median of 12.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apex Healthcare Bhd stock overvalued right now?
Apex Healthcare Bhd (XKLS:7090) has a current Return-on-Tangible-Equity of 7.98%. The stock's GF Value™ is RM2.27, compared to a current price of RM2.61 — trading 15% above its estimated fair value. The current Return-on-Tangible-Equity is 7.98%, which is 38% below median its 10-year median of 12.83 and 9.4% below the Medical Distribution industry median of 8.81. Apex Healthcare Bhd's overall GF Score™ is 63/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Apex Healthcare Bhd (XKLS:7090), the current Return-on-Tangible-Equity is 7.98% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apex Healthcare Bhd (XKLS:7090) Overvalued in 2026?
Based on GuruFocus' analysis, Apex Healthcare Bhd stock appears to be overvalued.
The current stock price of RM2.61 is trading 15% above its estimated GF Value™ of RM2.27.
Key valuation signals for XKLS:7090:
Return-on-Tangible-Equity: 7.98% (38% below median its 10-year median of 12.83)
GF Value™: RM2.27 vs. price of RM2.61 (15% above fair value)
Industry Position: 9.4% below the Medical Distribution median
No single metric tells the full story. See the XKLS:7090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apex Healthcare Bhd is an investment holding company for a group of companies engaged in the development, manufacturing, marketing, and distribution of pharmaceuticals, diagnostics, consumer healthcare products, and orthopedic devices. It has direct operations in Malaysia, Singapore and Others. The company has two manufacturing plants in Melaka and Penang. It has three segments: Manufacturing, Distribution and Corporate. It derives maximum revenue from Malaysia and also has a presence in Singapore and other couintries.
63GF Score
Get the complete analysis for XKLS:7090
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7090 has been successfully added to your 
